title: Endovascular treatment of peripheral vascular disease.
abstract: An estimated 10 million people in the U.S. have symptomatic peripheral arterial disease (PAD); 20 to 30 million have asymptomatic PAD. The prevalence of intermittent claudication increases with age, affecting >5% of patients over 70. The incidence of claudication doubles or triples in patients with diabetes. As people grow older, symptoms from peripheral vascular disease increasingly limit daily activity. Until recently, vascular surgical procedures were the only alternative to medical therapy in such patients. Today, advances in minimally invasive percutaneous interventions have made endovascular procedures the primary modality for revascularization in most patients. Compared with open surgical procedures, endovascular interventions offer comparable or superior long-term rates of success with very low rates for morbidity and mortality. Furthermore, most of these interventions are performed on an outpatient basis, reducing hospital stays considerably. In this monograph we discuss current endovascular interventions for treating occlusive PAD, aneurysmal arterial disease, and increasingly common venous occlusive diseases.
authors.affiliation: School of Medicine and Public Health-Milwaukee Clinical Campus, University of Wisconsin, Milwaukee, WI, USA.
authors.forename: Suhail
authors.initials: S
authors.lastname: Allaqaband
authors.forename: Joaquin
authors.initials: J
authors.lastname: Solis
authors.forename: Sepideh
authors.initials: S
authors.lastname: Kazemi
authors.forename: Tanvir
authors.initials: T
authors.lastname: Bajwa
mesh_terms: D000783:Aneurysm / Q000628:therapy; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D001158:Arteries / Q000473:pathology / Q000601:surgery; D005121:Extremities / Q000098:blood supply; D006801:Humans; D007511:Ischemia / Q000628:therapy; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D013479:Superior Vena Cava Syndrome / Q000628:therapy; D014481:United States / Q000453:epidemiology; D014656:Vascular Surgical Procedures / Q000295:instrumentation / Q000592:standards; D014680:Veins / Q000473:pathology / Q000601:surgery; D020246:Venous Thrombosis / Q000628:therapy
chemical_list: D010975:Platelet Aggregation Inhibitors